The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Analysis of DNA copy number in single cells using custom genome-wide targeted DNA sequencing panels for the Mission Bio Tapestri platform. Users can easily parse, manipulate, and visualize datasets produced from the automated 'Tapestri Pipeline', with support for normalization, clustering, and copy number calling. Functions are also available to deconvolute multiplexed samples by genotype and parsing barcoded reads from exogenous lentiviral constructs.
Version: | 1.0.1 |
Depends: | R (≥ 3.6), SingleCellExperiment |
Imports: | circlize, cli, ComplexHeatmap, dbscan, dplyr, fitdistrplus, GenomicRanges, ggplot2, gtools, IRanges, magrittr, methods, purrr, rhdf5, rlang, S4Vectors, stats, SummarizedExperiment, tibble, tidyr, umap, viridisLite |
Suggests: | Biostrings, knitr, rmarkdown, Rsamtools, testthat (≥ 3.0.0) |
Published: | 2023-09-07 |
DOI: | 10.32614/CRAN.package.karyotapR |
Author: | Joseph Mays [aut, cre, cph] |
Maintainer: | Joseph Mays <josephcmays at gmail.com> |
BugReports: | https://github.com/joeymays/karyotapR/issues |
License: | MIT + file LICENSE |
URL: | https://github.com/joeymays/karyotapR, http://joeymays.xyz/karyotapR/ |
NeedsCompilation: | no |
Materials: | README NEWS |
CRAN checks: | karyotapR results |
Reference manual: | karyotapR.pdf |
Package source: | karyotapR_1.0.1.tar.gz |
Windows binaries: | r-devel: karyotapR_1.0.1.zip, r-release: karyotapR_1.0.1.zip, r-oldrel: karyotapR_1.0.1.zip |
macOS binaries: | r-release (arm64): karyotapR_1.0.1.tgz, r-oldrel (arm64): karyotapR_1.0.1.tgz, r-release (x86_64): karyotapR_1.0.1.tgz, r-oldrel (x86_64): karyotapR_1.0.1.tgz |
Please use the canonical form https://CRAN.R-project.org/package=karyotapR to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.